JAK2 and acute lymphoblastic leukemia: For example, the Children's Oncology Group used a low-density gene expression array to identify Ph-like ALL.7 We are currently developing fluorescence in situ hybridization protocols for the detection of ABL1, PDGFRB and JAK2 rearrangements, which are targetable and relatively frequent genetic abnormalities.